Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 15 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2019OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALLEvans, K.; Duan, J.X.; Pritchard, T.; Jones, C.D.; McDermott, L.; Gu, Z.; Toscan, C.E.; El-Zein, N.; Mayoh, C.; Erickson, S.W.; Guo, Y.; Meng, F.; Jung, D.; Rathi, K.S.; Roberts, K.G.; Mullighan, C.G.; Shia, C.S.; Pearce, T.; Teicher, B.A.; Smith, M.A.; et al.
2011Myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8⁺CD4⁺ T cells: evidence from myeloma-bearing mouse modelFreeman, L.; Lam, A.; Petcu, E.; Smith, R.; Salajegheh, A.; Diamond, P.; Zannettino, A.; Evdokiou, A.; Luff, J.; Wong, P.; Khalil, D.; Waterhouse, N.; Vari, F.; Rice, A.; Catley, L.; Hart, D.; Vuckovic, S.
2015Colloidally stabilized magnetic carbon nanotubes providing MRI contrast in mouse liver tumorsLiu, Y.; Muir, B.W.; Waddington, L.J.; Hinton, T.M.; Moffat, B.A.; Hao, X.; Qiu, J.; Hughes, T.C.
2021Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanomaJacquelot, N.; Seillet, C.; Wang, M.; Pizzolla, A.; Liao, Y.; Hediyeh-Zadeh, S.; Grisaru-Tal, S.; Louis, C.; Huang, Q.; Schreuder, J.; Souza-Fonseca-Guimaraes, F.; de Graaf, C.A.; Thia, K.; Macdonald, S.; Camilleri, M.; Luong, K.; Zhang, S.; Chopin, M.; Molden-Hauer, T.; Nutt, S.L.; et al.
2020Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneityBrighi, C.; Reid, L.; Genovesi, L.A.; Kojic, M.; Millar, A.; Bruce, Z.; White, A.L.; Day, B.W.; Rose, S.; Whittaker, A.K.; Puttick, S.
2021Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: guidance using optical window intravital FRET imagingFloerchinger, A.; Murphy, K.J.; Latham, S.L.; Warren, S.C.; McCulloch, A.T.; Lee, Y.-K.; Stoehr, J.; Mélénec, P.; Guaman, C.S.; Metcalf, X.L.; Lee, V.; Zaratzian, A.; Da Silva, A.; Tayao, M.; Rolo, S.; Phimmachanh, M.; Sultani, G.; McDonald, L.; Mason, S.M.; Ferrari, N.; et al.
2019Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaBell, C.C.; Fennell, K.A.; Chan, Y.C.; Rambow, F.; Yeung, M.M.; Vassiliadis, D.; Lara, L.; Yeh, P.; Martelotto, L.G.; Rogiers, A.; Kremer, B.E.; Barbash, O.; Mohammad, H.P.; Johanson, T.M.; Burr, M.L.; Dhar, A.; Karpinich, N.; Tian, L.; Tyler, D.S.; MacPherson, L.; et al.
2021CDK4/6 inhibition promotes antitumor immunity through the induction of T-cell memoryLelliott, E.J.; Kong, I.Y.; Zethoven, M.; Ramsbottom, K.M.; Martelotto, L.G.; Meyran, D.; Zhu, J.J.; Costacurta, M.; Kirby, L.; Sandow, J.J.; Lim, L.; Dominguez, P.M.; Todorovski, I.; Haynes, N.M.; Beavis, P.A.; Neeson, P.J.; Hawkins, E.D.; McArthur, G.A.; Parish, I.A.; Johnstone, R.W.; et al.
2015Progesterone receptor modulates ERα action in breast cancerMohammed, H.; Russell, I.; Stark, R.; Rueda, O.; Hickey, T.; Tarulli, G.; Serandour, A.; Birrell, S.; Bruna, A.; Saadi, A.; Menon, S.; Hadfield, J.; Pugh, M.; Raj, G.; Brown, G.; D'Santos, C.; Robinson, J.; Silva, G.; Launchbury, R.; Perou, C.; et al.
2012The Oncogenic role of miR-155 in breast cancerMattiske, S.; Suetani, R.; Neilsen, P.; Callen, D.